Clinical Evaluation of Radiation Reduction for Optimized Safety

ConditionsCoronary Artery Disease Myocardial Infarction Coronary Disease Coronary Stenosis Angina Pectoris Chest Pain

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorAngiowave Imaging

About this trial

The primary objective of this study is to determine whether a reduced radiation protocol (RRP) in which angiograms are acquired at ultralow radiation doses and then processed using spatiotemporal enhancement software can produce similar quality angiographic images as compared with standard techniques.

Eligibility criteria

Qualifiers

Referred for clinically indicated coronary angiography

≥18 years of age

Not pregnant

English speaking

Disqualifiers

Hemodynamically or electrically unstable.

Indication for coronary angiography is emergent, including ST-segment elevation myocardial infarction

History of coronary artery bypass grafting

An eGFR <60

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Angiowave Imaging

Lead sponsor

Source ClinicalTrials.gov